Travere Therapeutics, Inc. (TVTX)
Since May 14, 2014, Travere Therapeutics, Inc. (TVTX) has reported earnings 47 times. On average the shares move ±5.26% post-earnings, with a positive reaction 40.4% of the time. Its largest post-earnings gain was +18.58% (Oct 30, 2025) and its largest decline was -14.85% (May 06, 2021). The next earnings report is predicted for 2026-08-04 (approximate).
Earnings reactions
How TVTX moved on each past earnings report.
Earnings Impact
Total Earnings
47
Avg Abs. Movement
±5.26%
Positive %
40.4%
Negative %
59.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 04, 2026 | ☽ POST | -0.26% | open_in_new |
| Feb 19, 2026 | ☽ POST | +3.72% | open_in_new |
| Oct 30, 2025 | ☽ POST | +18.58% | open_in_new |
| Aug 06, 2025 | ☽ POST | -1.91% | open_in_new |
Earnings Count
47
Total earnings in dataset
Avg Abs. Movement
±5.26%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260709 | open_in_new SEC.gov |
| 4 | 20260622 | open_in_new SEC.gov |
| S-8 | 20260617 | open_in_new SEC.gov |
| 4 | 20260616 | open_in_new SEC.gov |
| 4 | 20260616 | open_in_new SEC.gov |
| 8-K | 20260616 | open_in_new SEC.gov |
| 144 | 20260612 | open_in_new SEC.gov |
| 144 | 20260612 | open_in_new SEC.gov |
| 8-K | 20260602 | open_in_new SEC.gov |
| 4 | 20260521 | open_in_new SEC.gov |
Frequently asked about TVTX earnings
When does Travere Therapeutics, Inc. report earnings next? expand_more
Travere Therapeutics, Inc. (TVTX)'s next earnings date is approximate for 2026-08-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does TVTX stock move after earnings? expand_more
Over 47 reports, TVTX has moved an average of ±5.26% the session after earnings, closing higher 40.4% of the time.
What was TVTX's biggest post-earnings move? expand_more
TVTX's largest post-earnings gain on record was +18.58% on Oct 30, 2025, and its largest decline was -14.85% on May 06, 2021.
Where can I find Travere Therapeutics, Inc.'s SEC filings? expand_more
All of Travere Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- Allegiant Travel CO (ALGT) earnings 2026-08-03
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arbutus Biopharma Corp (ABUS) earnings 2026-08-03
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04